Embolex and Stools - watery - a phase IV clinical study of FDA data

Summary:

Stools - watery is reported as a side effect among people who take Embolex (dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Avastin, and have High blood pressure.

The phase IV clinical study analyzes which people have Stools - watery when taking Embolex. It is created by eHealthMe based on reports of 1,159 people who have side effects when taking Embolex from the FDA, and is updated regularly.

What is Embolex?

Embolex has active ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride. eHealthMe is studying from 1,161 Embolex users. Check the latest studies of Embolex.

What is Stools - watery?

Stools - watery is found to be associated with 4,694 drugs and 5,937 conditions by eHealthMe. Check the latest studies of Stools - watery.

On Jul, 12, 2026

1,159 people reported to have side effects when taking Embolex.
Among them, 71 people (6.13%) have Stools - watery.

Among these 71 people:

How long have people been on Embolex when they have Stools - watery? *

What is the gender of people who have Stools - watery when taking Embolex? *

female: 65.71 %
male: 34.29 %

What is the age of people who have Stools - watery when taking Embolex? *

What are other drugs people take besides Embolex? *

What are other side effects people have besides Stools - watery? *

Dehydration (dryness resulting from the removal of water): 26 people, 36.62%
Dizziness: 23 people, 32.39%
Fatigue (feeling of tiredness): 23 people, 32.39%
Nausea And Vomiting: 20 people, 28.17%
General Physical Health Deterioration (weak health status): 20 people, 28.17%
Circulatory Collapse: 19 people, 26.76%
Joint Pain: 18 people, 25.35%
Nosebleed (bleeding from nose): 17 people, 23.94%
Hypokalemia (low potassium): 16 people, 22.54%
Back Pain: 16 people, 22.54%

What are the existing conditions these people have? *

High Blood Pressure: 29 people, 40.85%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 23 people, 32.39%
Iron Deficiency: 15 people, 21.13%
Venous Thrombosis (blood clot (thrombus) that forms within a vein): 9 people, 12.68%
Colon Cancer: 9 people, 12.68%
Sleep Disorder: 9 people, 12.68%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 8 people, 11.27%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 7 people, 9.86%
Joint Pain: 7 people, 9.86%
Cancer Pain: 7 people, 9.86%

* Approximation only. Some reports may have incomplete information.

Do you take Embolex and have Stools - watery?

- Check whether Stools - watery is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Embolex:

Embolex (1,161 reports)

Stools - watery treatments and more:

Stools - watery (756,290 reports)

How severe was Stools - watery and when was it recovered:

Stools - watery in Embolex

Expand to all the drugs that have ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride:

Stools - watery and drugs with ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride (71 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Embolex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stools - watery:

Stools - watery (4,694 drugs)

Browse all the conditions that are associated with Stools - watery:

Stools - watery (5,937 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride (the active ingredients of Embolex) and Embolex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.